Skip to content

Anger and Psychotrauma: Data From Military and Civilians

Anger and Psychotrauma: Data From Military and Civilians

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04518267
Acronym
COPMiCiv
Enrollment
50
Registered
2020-08-19
Start date
2020-09-21
Completion date
2024-09-30
Last updated
2023-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-traumatic Stress Disorder

Brief summary

Post-Traumatic Stress Disorder (PTSD) is mainly associated with several emotions such as anger, guilt or shame. By interfering with psychotherapeutic work these emotions can be problematic. When suffering from PTSD, pervasive anger can also have relational consequences. Anger and PTSD are mutually reinforcing: anger can aggravate PTSD symptoms and aggressive behaviours, and conversely, PTSD promotes high levels of anger and aggression. A few explanatory hypotheses have been proposed. In terms of personality factors, anger-treatment may promote the severity of PTSD symptoms and the development of aggressive behaviours. In terms of stressors, exposure to combat and combat-related moral harms could play a role in the relationship between PTSD, anger and traumatic experiences over the course of life. Finally, in clinical terms, in the presence of PTSD, anger and aggressive behaviours may be triggered by substance abuse and depression. Within the Anglo-Saxon literature, it is recognized that both civilians and military personnel with PTSD exhibit high levels of anger, with a possible predominance among military personnel. While we know that anger management mechanisms can be strongly influenced by cultural aspects and the type of event, there is no data in the French population. This study proposes to fill in our knowledge of anger-PSTD relationships in the French population and by comparing civilian and military population.

Interventions

BEHAVIORALStructured clinical interview

A structured clinical interview will be performed at enrollment.

Several psychological questionnaires will be performed at enrollment.

Sponsors

Direction Centrale du Service de Santé des Armées
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* To have a PTSD diagnosis * To be at least 18 years of age

Exclusion criteria

* To suffer from trauma-related physical condition (including Traumatic Brain Injury)

Design outcomes

Primary

MeasureTime frameDescription
PTSD severity scoreAt enrollmentClinician-Administered Posttraumatic Stress Disorder Scale (CAPS-5) will be used to assess PTSD severity score. CAPS-5 score may range from 0 to 120 with higher scores meaning greater PTSD severity.
Number of life traumatic eventsAt enrollmentLife Event Checklist (LEC) will be used to assess the number of traumatic events experienced by participants throughout their lifetime
Anxiety scoreAt enrollmentSpielberger's State-Trait Anger Expression Inventory-II (STAXI-II) will be used to assess anxiety

Secondary

MeasureTime frameDescription
Aggressivity scoreAt enrollmentAggressivity Questionnaire (AQ12) will be used to assess aggressivity score. AQ12 score may range from 6 to 72 with higher scores meaning higher aggressivity levels.
Anger Rumination scoreAt enrollmentAnger Rumination Scale (ARS) will be used to assess anger rumination score. ARS score may range from 19 to 76 with higher scores corresponding to greater levels of anger rumination.
Alcohol consumption scoreAt enrollmentAlcohol Use Identification Test (A.U.D.I.T.) will be used to assess alcohol consumption score Score ≥ 5: at risk use; Score ≥ 8 (7 in women): harmful use; Score ≥ 12 (11 in women): likely alcohol dependence

Countries

France

Contacts

Primary ContactAnaïs MARMUSE
anais.marmuse@intradef.gouv.fr328382250

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026